跳至主要内容
临床试验/EUCTR2005-001139-31-IT
EUCTR2005-001139-31-IT进行中(未招募)不适用

A protocol for localized non rhabdomyosarcoma Soft Tissue Sarcomas, in paediatric age - EpSSG NRSTS 2005

AZIENDA OSPEDALIERA DI PADOVA0 个研究点目标入组 450 人开始时间: 2006年5月29日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
450

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1)pathologically proven diagnosis of synovial sarcomas or adult-type soft tissue sarcomas; 2)age less than 21 years; 3)no evidence of metastatic disease; 4)no previous treatment except for primary surgery; 5) diagnostic specimens available for pathological review; 6) written consent.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1)Diagnosis of NRSTS not pathologically proven; 2)age > 21 years; 3) evidence of metastastatic disease at diagnosis; 4)previous treatment for other tumours.

研究者

发起方
AZIENDA OSPEDALIERA DI PADOVA

相似试验

进行中(未招募)
不适用
a protocol for patients with localized rhabdomyosarcoma in pediatric age - EpSSG RMS 2005healthy voluntaries are not included in the studyMedDRA version: 14.1Level: PTClassification code 10039022Term: RhabdomyosarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2005-000217-35-ITAZIENDA OSPEDALIERA DI PADOVA600
进行中(未招募)
不适用
Treatment of children and young people presenting with non-metastatic rhabdomyosarcoma.
EUCTR2005-000217-35-BEHôpital Universitaire Des Enfants Reine Fabiola (H.U.D.E.R.F.)600
进行中(未招募)
不适用
RMS 2005: a protocol for non metastatic rhabdomyosarcomarhabdomyosarcoma no metastaticMedDRA version: 14.1Level: PTClassification code 10039022Term: RhabdomyosarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2005-000217-35-ESDr Jose Sanchez de Toledo Codina700
进行中(未招募)
不适用
ocal cytoreductive treatments for men with newly diagnosed metastatic prostate cancer in addition to standard of care treatmentProstate cancerCancer
ISRCTN58401737Imperial College London and Imperial College Healthcare NHS Trust399
招募中
不适用
Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy - A randomized controlled pilottrial (Optitreat)C15C16Malignant neoplasm of oesophagusMalignant neoplasm of stomach
DRKS00004668niversitätsklinikum HeidelbergKlinik für Allgemein-, Viszeral- und Transplantationschirurgie120